17 Publications
2019
Caenorhabditis elegans as a model system to identify therapeutics for alcohol use disorders
Katner, Simon NKatner, Simon NBredhold, Kristin EBredhold, Kristin ESteagall, Kevin BSteagall, Kevin BBell, Richard LBell, Richard LNeal-Beliveau, Bethany SNeal Beliveau, Bethany SCheong, Mi CCheong, Mi CEngleman, Eric A and Engleman, Eric A
Behavioural Brain Research, vol. 365, pp. 16, 2019-06-03. | Journal Article
2018
Caenorhabditis elegans Show Preference for Stimulants and Potential as a Model Organism for Medications Screening
Engleman, Eric AEngleman, Eric ASteagall, 2nd, Kevin BSteagall, 2nd, Kevin BBredhold, Kristin EBredhold, Kristin EBreach, MichaelaBreach, MichaelaKline, Hannah LKline, Hannah LBell, Richard LBell, Richard LKatner, Simon NKatner, Simon NNeal-Beliveau, Bethany S and Neal Beliveau, Bethany S
Frontiers in physiology, vol. 9, pp. 1200, 2018-00-00. | Journal Article
2016
Caenorhabditis elegans as a model to study the molecular and genetic mechanisms of drug addiction
Engleman, Eric AEngleman, Eric AKatner, Simon NKatner, Simon NNeal Beliveau, Bethany S and Neal-Beliveau, Bethany S
Progress in molecular biology and translational science, vol. 137, pp. 252, 2016-00-00. | Journal Article
 
Embryonic Methamphetamine Exposure Inhibits Methamphetamine Cue Conditioning and Reduces Dopamine Concentrations in Adult N2 Caenorhabditis elegans
Katner, Simon NKatner, Simon NNeal-Beliveau, Bethany SNeal Beliveau, Bethany SEngleman, Eric A and Engleman, Eric A
Developmental Neuroscience, vol. 38, (no. 2), pp. 149, 20160600. | Journal Article
2012
Chemosensory Cue Conditioning With Stimulants in a Caenorhabditis Elegans Animal Model of Addiction
Musselman, Heather NMusselman, Heather NMusselman, Heather NNeal-Beliveau, BethanyNeal Beliveau, BethanyNeal-Beliveau, BethanyNass, RichardNass, RichardNass, RichardEngleman, Eric AEngleman, Eric A and Engleman, Eric A
Behavioral Neuroscience, vol. 126, (no. 3), pp. 456, 20120600. | Journal Article
2008
Poster 9: Anticholinergic Drugs and Severity of Post-Brain Injury Delirium
Holder, MaleneKean, JacobTrzepacz, PaulaMalec, JamesNeal Beliveau, Bethany and Williams, Jane
Archives of Physical Medicine and Rehabilitation, vol. 89, (no. 10), pp. e31, 2008. | Journal Article
2006
Amphetamine Lowers Brain Stimulation Reward (BSR) Threshold in Alcohol-Preferring (P) and -Nonpreferring (NP) Rats
Eiler, William J. AMasters, JacobMcKay, Pete FHardy, LathenGoergen, JoshMensah-Zoe, BoikaiSeyoum, RegatCook, JasonJohnson, NathanNeal Beliveau, Bethany and June, Harry L
Experimental and Clinical Psychopharmacology, vol. 14, (no. 3), pp. 376, 20060800. | Journal Article
 
Amphetamine lowers brain stimulation reward (BSR) threshold in alcohol-preferring (P) and -nonpreferring (NP) rats: regulation by D-sub-1 and D-sub-2 receptors in the nucleus accumbens
Eiler, BillEiler, 2nd, William J AMasters, JacobMasters, JacobMcKay, Pete FMcKay, Pete FHardy, LathenHardy, 3rd, LathenGoergen, JoshGoergen, JoshMensah-Zoe, BoikaiMensah-Zoe, BoikaiSeyoum, RegatSeyoum, RegatCook, JasonCook, JasonJohnson, NathanJohnson, NathanNeal-Beliveau, BethanyNeal Beliveau, BethanyJune, Harry L and June, Harry L
Experimental and clinical psychopharmacology, vol. 14, (no. 3), pp. 361, 2006-Aug. | Journal Article
2005
Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion
Xu, Zao CXu, Zao CLing, GuangyiLing, G.Sahr, RNSahr, Robert NNeal-Beliveau, BS and Neal Beliveau, Bethany S
Brain Research, vol. 1038, (no. 2), pp. 170, 2005. | Journal Article
1999
Timing: A Critical Determinant of the Functional Consequences of Neonatal 6-OHDA Lesions
Neal Beliveau, Bethany S and Joyce, JN
Neurotoxicology and Teratology, vol. 21, (no. 2), pp. 129-140, 1999. | Journal Article
1998
Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal Beliveau, Bethany S and Joyce, J N
Developmental Psychobiology, vol. 32, (no. 4), pp. 313-26, 1998/May. | Journal Article
 
There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum
Thomas, Wendy SNeal Beliveau, Bethany S and Joyce, Jeffrey N
Developmental Brain Research, vol. 111, (no. 1), pp. 106, 1998. | Journal Article
1996
Functional and molecular differentiation of the dopamine system induced by neonatal denervation.
Joyce, J NFrohna, P A and Neal Beliveau, Bethany S
Neuroscience and biobehavioral reviews, vol. 20, (no. 3), pp. 453-86, 1996. | Journal Article
1993
D1 and D2 dopamine receptors do not up-regulate in response to neonatal intrastriatal 6-hydroxydopamine lesions.
Neal Beliveau, Bethany S and Joyce, J N
Neuroscience Letters, vol. 160, (no. 1), pp. 77-80, 1993/Sep/17. | Journal Article
 
Serotonergic involvement in haloperidol-induced catalepsy.
Neal Beliveau, Bethany SJoyce, J N and Lucki, I
The Journal of Pharmacology and Experimental Therapeutics, vol. 265, (no. 1), pp. 207-17, 1993/Apr. | Journal Article
1992
Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
Neal Beliveau, Bethany S and Joyce, J N
Synapse (New York, N.Y.), vol. 11, (no. 1), pp. 35-46, 1992/May. | Journal Article
1988
Blockade of quasi-opioid withdrawal in mature and developing rats by serotonin(2) receptor antagonists (Dissertation)
Neal Beliveau, Bethany S (1988).